Highlights of Prescribing Information: SAXENDA (liraglutide) Injection, for subcutaneous use
It won approval from the Ministry of Food and Drug Safety in 2017
This does not exclude the possibility of skin sensitivity occurring in a subset of patients, particularly as Phase 3 trials enrol larger and more diverse populations
These weight-loss treatments may also influence broader factors tied to workplace performance, including energy, focus and long-term productivity, according to research published in The New England Journal of Medicine and analyses from organizations such as the World Economic Forum and McKinsey & Company, said Forbes
Compounded semaglutide remains legal under the 503A patient-specific compounding pathway when prepared by licensed compounding pharmacies for individual patients with valid prescriptions, including documented clinical rationale
If you need to find programs and services in your community, call or text 211 or visit 211 Alberta